Role of adjuvant chemotherapy for lymph node‐positive upper tract urothelial carcinoma and the prognostic significance of C‐reactive protein: A multi‐institutional, retrospective study

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 11, 2015-11 ,pp. : 1006-1012

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology–Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration

By  

BJU INTERNATIONAL, Vol. 121, Iss. 2, 2018-02 ,pp. : 252-259

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adjuvant cisplatin‐based combined chemotherapy for lymph node (LN)‐positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of

By  

BJU INTERNATIONAL, Vol. 115, Iss. 5, 2015-05 ,pp. : 722-727

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive Factors for Bladder Recurrence after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

By  

Urologia Internationalis, Vol. 91, Iss. 2, 2013-02 ,pp. : 153-159

Karger

Access to resources Recommend Favorite

Preoperative C-Reactive Protein in the Serum: A Prognostic Biomarker for Upper Urinary Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy

By  

Urologia Internationalis, Vol. 93, Iss. 3, 2014-08 ,pp. : 352-360

Karger

Access to resources Recommend Favorite